Pardes Biosciences Operating Income

Pardes Biosciences posts a operating income of $-85M as of June 2023. That compares with $-75M in the prior-year period — down 12.1% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Pardes Biosciences's operating income was $-75M. The latest reading is $-85M — a 12.1% year-over-year decrease (period ending June 2023). Use the history and growth charts on this page for a longer lookback.

Operating Income is one piece of Pardes Biosciences's financial statement story. At $-85M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for PRDS's operating income usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Pardes Biosciences's other metric pages and overview cover the third.